Jingru Zhao , Lipeng Dong , Xin Gong , Shuo Hui , Xinyao Wang , Siyu Tian , Yuanyuan Liu , Tiantian Huo , Yanzhao Xie , Yanzhong Chang
{"title":"Hepcidin/HIF-1α is involved in the endogenous recovery and ferroptosis after cerebral ischemia in mice","authors":"Jingru Zhao , Lipeng Dong , Xin Gong , Shuo Hui , Xinyao Wang , Siyu Tian , Yuanyuan Liu , Tiantian Huo , Yanzhao Xie , Yanzhong Chang","doi":"10.1016/j.bbadis.2025.168022","DOIUrl":null,"url":null,"abstract":"<div><div>It is common to witness a spontaneous endogenous recovery process with the potential mechanisms involving the remyelination, nerve regeneration, and synaptic plasticity, which might be vital for the neurological rehabilitation after cerebral ischemic stroke. Iron homeostasis is considered to be crucial for myelination and neuronal metabolic processes, and Hepcidin is an important factor in regulating iron homeostasis and ferroptosis. Hypoxia-inducible factor (HIF) is an important hypoxia tolerance factor and can regulate cell survival in hypoxia environment, which is critical to regulate iron homeostasis as well. Nevertheless, the effect of Hepcidin on endogenous injury repair during cerebral ischemia recovery period and whether Hepcidin could regulate ferroptosis via HIF-1α remain unclear. Here, we established the distal middle cerebral artery occlusion (dMCAO) mice model to investigate the effect of Hepcidin on endogenous injury repair and ferroptosis during cerebral ischemia recovery and HIF-1α-associated mechanisms. Our results indicated that Hepcidin/HIF-1α pathway played a crucial role in regulating ferroptosis as well as endogenous injury repair and subsequent neurological recovery after cerebral ischemia, serving as a possible target for the treatment of recovery after stroke.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 8","pages":"Article 168022"},"PeriodicalIF":4.2000,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et biophysica acta. Molecular basis of disease","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0925443925003709","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
It is common to witness a spontaneous endogenous recovery process with the potential mechanisms involving the remyelination, nerve regeneration, and synaptic plasticity, which might be vital for the neurological rehabilitation after cerebral ischemic stroke. Iron homeostasis is considered to be crucial for myelination and neuronal metabolic processes, and Hepcidin is an important factor in regulating iron homeostasis and ferroptosis. Hypoxia-inducible factor (HIF) is an important hypoxia tolerance factor and can regulate cell survival in hypoxia environment, which is critical to regulate iron homeostasis as well. Nevertheless, the effect of Hepcidin on endogenous injury repair during cerebral ischemia recovery period and whether Hepcidin could regulate ferroptosis via HIF-1α remain unclear. Here, we established the distal middle cerebral artery occlusion (dMCAO) mice model to investigate the effect of Hepcidin on endogenous injury repair and ferroptosis during cerebral ischemia recovery and HIF-1α-associated mechanisms. Our results indicated that Hepcidin/HIF-1α pathway played a crucial role in regulating ferroptosis as well as endogenous injury repair and subsequent neurological recovery after cerebral ischemia, serving as a possible target for the treatment of recovery after stroke.
期刊介绍:
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.